IRCT20141201020178N9已完成2 期
The Efficacy of Adding Daflon to the Conventional Treatment on the Improvement of Symptoms and Health-Related Quality of Life in the Patients with Acute Hemorrhoids: A randomized clinical trial
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •age more than 18 years
- •acute hemorrhoid crisis(anal pain and anal bleeding)
排除标准
- •Grade I and IV of hemorrhoid
- •previous history of surgery related to the anorectal or hemorrhoid disease
- •Patients with the history of other chronic systemic diseases, such as heart, kidney, or liver disease, hypertension, seizure
- •cancer history
- •medications such as anti-depressant and flavonoid drugs
- •non-cooperative
- •sleep disorders
- •allergy to daflon
研究者
相似试验
尚未招募
3 期
Effect of dapagliflozin on bone healthCTRI/2022/04/041622Department of Endocrinology
尚未招募
不适用
The evaluation of effects of Daflon tablet on hemorrhoidsHemorrhoids.Hemorrhoids and perianal venous thrombosisIRCT20210625051698N1Karaj University of Medical Sciences200
尚未招募
不适用
Dapagliflozin in Heart FailureCTRI/2022/11/047725Sanjay Kumar R
进行中（未招募）
不适用
Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomatic Chronic Venous Disease (CVD).Patients suffering from symptomatic Chronic Venous Disease (CVD).MedDRA version: 14.1Level: LLTClassification code 10066682Term: Chronic venous insufficiencySystem Organ Class: 100000004866EUCTR2012-003559-13-ESInstitut de Recherches Internationales Servier952
进行中（未招募）
不适用
Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomatic Chronic Venous Disease (CVD).EUCTR2012-003559-13-CZInstitut de Recherches Internationales Servier952